Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-day Comparator in Subjects 12 to < 18 Years With cSSTI.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02276482
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:12.107827+00:00
Published At
2019-08-07T00:00:00+00:00
Record Updated At
2019-08-07
Results Posted At
2019-08-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Skin Diseases, Infectious", "Skin Diseases, Bacterial"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-08-07"
protocolSection.identificationModule.nctId
"NCT02276482"
protocolSection.identificationModule.officialTitle
"Phase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-day Comparator in Subjects 12 to \u003c 18 Years With cSSTI."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-08-07"

Study condition terms

  • Skin Diseases, Infectious (protocolSection.conditionsModule.conditions)
  • Skin Diseases, Bacterial (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.